Secondary sideroblastic anaemia

DOID EFO MESH PheWeb

D3_SIDEROANASCND

anemia (phenotype): ['A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.']

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D64.1, D64.2#

Hospital discharge: ICD-9 2850B

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D64.1, D64.2#

Cause of death: ICD-9 2850B

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

D3_SIDEROANASCND

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Secondary sideroblastic anaemia based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Secondary sideroblastic anaemia due to drugs and toxins

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	62	31	31
Unadjusted prevalence (%)	0.02	0.02	0.02
Mean age at first event (years)	63.45	57.44	69.45

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_SIDEROANASCND – Secondary sideroblastic anaemia
GWS hits:

Survival analyses between endpoints

↥

Plot

before Secondary sideroblastic anaemia
after Secondary sideroblastic anaemia

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Secondary sideroblastic anaemia

↥